Lower dose radiation — and only one treatment — works just as well for lung cancer patients

Roswell Park research finds shorter treatment course effective, and lessens burden on patients

Highlights
  • One lower-dose radiation treatment just as effective as standard three sessions
  • The one-time treatment did not increase side effects
  • Shorter treatment lessens travel demands, time away from work and family

For people diagnosed with early-stage lung cancer who are unable to have surgery, radiation therapy is often an important treatment option. New research from Roswell Park Comprehensive Cancer Center suggests that many of these patients may be able to receive just one radiation treatment at half the usual dose, with results that are just as effective as the current standard approach.

The findings could make treatment more convenient for patients while reducing time spent traveling to appointments and potentially lowering healthcare costs.

Why this research matters

Lung cancer is the leading cause of cancer-related deaths in the United States. About 85% of lung cancer cases are a type called non-small cell lung cancer (NSCLC).

For patients with early-stage NSCLC, surgery is often considered the best treatment. However, not everyone is healthy enough to undergo an operation. Older adults and people with other medical conditions may face risks that make surgery unsafe.

In these situations, doctors frequently recommend stereotactic body radiation therapy (SBRT), a highly targeted form of radiation treatment designed to destroy tumors while minimizing damage to surrounding healthy tissue. Traditionally, many patients receive SBRT over three to five separate treatment sessions. But researchers wanted to know whether patients could achieve the same results with a single treatment session using a lower total radiation dose.

The answer could have an important impact on patients' lives. Fewer appointments can mean less disruption to work, family responsibilities and daily routines. This may be especially valuable for people who must travel long distances to reach a cancer center.

How does it work?

SBRT is different from conventional radiation therapy. Instead of delivering lower doses of radiation over many weeks, SBRT uses advanced imaging and precise targeting to deliver a concentrated dose directly to the tumor. Because the treatment is so accurate, doctors can focus radiation on the cancer while limiting exposure to nearby healthy organs and tissues.

Researchers led by Dr. Anurag Singh of Roswell Park studied whether a lower-dose, single-session approach could provide the same level of cancer control as the standard three-treatment regimen. The clinical trial enrolled 98 patients with early-stage NSCLC whose tumors were located in the outer areas of the lung, known as peripheral lung tumors. None of the patients were candidates for surgery. Participants were randomly assigned to one of two treatment groups:

  • Standard treatment: 60 gray (Gy) of radiation delivered across three SBRT sessions.
  • Single-treatment approach: 30 Gy of radiation delivered in one SBRT session.

Patients were followed for up to five years so researchers could compare survival rates, cancer recurrence and treatment-related side effects. The results were encouraging: Patients who received the lower-dose, one-session treatment had outcomes comparable to those who received the traditional three-session treatment. Researchers found:

  • No difference in overall survival.
  • No increase in cancer growth or spread.
  • No increase in radiation-related side effects.
  • Significantly fewer visits for treatment.

According to the study team, the findings suggest that carefully selected patients with peripheral early-stage lung tumors can safely receive a single SBRT treatment without sacrificing effectiveness.

Why choose Roswell Park for lung cancer care

You owe it to yourself to take time now to ensure your treatment plan is the right one for you.

Learn more about getting a second opinion

What this means for patients

For many patients, cancer treatment affects more than just their health. Transportation, time away from work, caregiving responsibilities and treatment costs can all create additional challenges. A one-time treatment approach could help reduce some of those burdens.

Patients who live in rural communities or far from a treatment center may especially benefit. Instead of making multiple trips for radiation, they could potentially complete treatment in a single visit. The lower-dose approach may also reduce healthcare costs by decreasing the number of treatment sessions required, while maintaining the same outcomes for appropriately selected patients.

Importantly, the study does not mean that every person with lung cancer should receive one treatment instead of three. Treatment decisions depend on many factors, including the type of cancer, its location, the patient's overall health and other individual considerations. The findings apply specifically to patients with early-stage non-small cell lung cancer located in the outer portions of the lung who are not candidates for surgery.

Still, the research provides strong evidence that a shorter treatment schedule can be both safe and effective for many patients. As cancer care continues to evolve, studies like this help identify ways to not only treat cancer successfully but also reduce the burden of treatment on patients and their families. For patients facing early-stage lung cancer, this simpler approach may offer something many people value just as much as effective treatment: more time spent living life, and less time spent in the clinic.